This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Walker, C. Articles by Low, B. Search for Related Content PubMed PubMed Citation Articles by Walker, C. Articles by Low, B.

(American Journal of Pathology. 2006;168:1526-1530.)
© 2006 American Society for Investigative Pathology

Mortalin-Based Cytoplasmic Sequestration of p53 in a Nonmammalian Cancer Model

From the Department of Zoology, Center for Marine Biology and Marine Biomedical Research Group, University of New Hampshire, Durham, New Hampshire

In nature the soft shell clam Mya arenaria develops a fatal neoplasm that shares molecular similarity with an unrelated group of human cancers. In leukemic clam hemocytes, wild-type p53 and mortalin proteins co-localize in the cytoplasm. A similar phenotype, characterized by cytoplasmic sequestration of wild-type p53 protein, has been observed in several human cancers (undifferentiated neuroblastoma, retinoblastoma, colorectal and hepatocellular carcinomas, and glioblastoma). In some of these cancers p53 is tethered in the cytoplasm by mortalin when the latter protein is overexpressed. Using co-immunoprecipitation we have demonstrated that mortalin and p53 proteins are complexed in the cytoplasm of leukemic clam hemocytes (and not in normal hemocytes). In addition, treatment of leukemic clam hemocytes with MKT-077, a cationic inhibitor of mortalin, disrupts the interaction of mortalin and p53 proteins, resulting in translocation of some p53 to the nucleus. Based on these data, we introduce leukemic clam hemocytes as novel and easily accessible, in vivo and in vitro models for human cancers displaying a similar mortalin-based phenotype. Treatment of these models with novel chemotherapeutics may help reveal the molecular mechanism(s) involved in inactivating p53 by this form of cytoplasmic sequestration.

This article has been cited by other articles:

				R. Wadhwa, J. Ryu, R. Gao, I.-K. Choi, G. Morrow, K. Kaur, I. Kim, S. C. Kaul, C.-O. Yun, and R. M. Tanguay Proproliferative Functions of Drosophila Small Mitochondrial Heat Shock Protein 22 in Human Cells J. Biol. Chem., February 5, 2010; 285(6): 3833 - 3839. [Abstract] [Full Text] [PDF]

				C. Walker, S. A. Bottger, J. Mulkern, E. Jerszyk, M. Litvaitis, and M. Lesser Mass Culture and Characterization of Tumor Cells From a Naturally Occurring Invertebrate Cancer Model: Applications for Human and Animal Disease and Environmental Health Biol. Bull., February 1, 2009; 216(1): 23 - 39. [Abstract] [Full Text] [PDF]

				J. C. Ghosh, T. Dohi, B. H. Kang, and D. C. Altieri Hsp60 Regulation of Tumor Cell Apoptosis J. Biol. Chem., February 22, 2008; 283(8): 5188 - 5194. [Abstract] [Full Text] [PDF]

				S. Bottger, E. Jerszyk, B. Low, and C. Walker Genotoxic Stress-Induced Expression of p53 and Apoptosis in Leukemic Clam Hemocytes with Cytoplasmically Sequestered p53 Cancer Res., February 1, 2008; 68(3): 777 - 782. [Abstract] [Full Text] [PDF]

				M. B. Gill, J. L. Kutok, and J. D. Fingeroth Epstein-Barr Virus Thymidine Kinase Is a Centrosomal Resident Precisely Localized to the Periphery of Centrioles J. Virol., June 15, 2007; 81(12): 6523 - 6535. [Abstract] [Full Text] [PDF]